Clinical trial
Evaluation of the Efficacy of the Opioid Antagonist Naltrexone on the Incidence and Intensity of Flashbacks and Dissociative States in Patients With Borderline Personality Disorder
NCT00124839 is registered in ClinicalTrials.gov with Central Institute of Mental Health, Mannheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of the Opioid Antagonist Naltrexone on the Incidence and Intensity of Flashbacks and Dissociative States in Patients With Borderline Personality Disorder
- Lead sponsor
- Central Institute of Mental Health, Mannheim
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- October 31, 2005
- Completion date
- March 31, 2008
- Enrollment
- 48 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.